Biolabeling Reagents Line

Experimental Objective

The project aimed to:

• Develop a hypoxia-responsive imaging platform
• Monitor oxygen concentration changes in live tumor cells
• Achieve long-term phosphorescence imaging with minimal photobleaching
• Improve signal-to-background ratio during confocal microscopy analysis

Application Process

The iridium complex was conjugated to a peptide-based targeting ligand through the carboxyl-functionalized bipyridyl moiety. The resulting phosphorescent probe was incubated with cultured tumor spheroids under normoxic and hypoxic conditions.

Confocal laser scanning microscopy and time-resolved luminescence measurements were performed to evaluate intracellular phosphorescence behavior and oxygen sensitivity.

Results and Findings

The researchers observed:

• The probe exhibited strong red phosphorescence emission centered at approximately 620 nm with a quantum yield of about 0.34.
• After continuous laser irradiation for 30 min, the phosphorescence intensity retained more than 87% of its initial value, while the conventional organic fluorescent dye control retained only approximately 52%.
• Under hypoxic conditions (1% O₂), phosphorescence intensity increased by approximately 3.8-fold compared with normoxic conditions.
• The intracellular signal-to-noise ratio (S/N) reached 18.6, significantly higher than the 9.4 observed for conventional fluorescent probes.
• More than 78% intracellular retention was maintained after 24 h incubation.
• MTT cytotoxicity analysis showed cell viability remained above 92% at a probe concentration of 10 μM.

These results demonstrated that the iridium complex provided highly stable and sensitive hypoxia-responsive imaging performance in complex biological environments..

Customer Feedback

"The research team highlighted the compound’s high photostability, consistent batch quality, and reliable phosphorescence properties as critical advantages for their live-cell imaging experiments."

Experimental Objective

The study focused on:

• Developing a fluorescent protein interaction assay
• Evaluating fluorescence lifetime behavior in aqueous biological systems
• Improving sensitivity in biomolecular detection
• Reducing nonspecific fluorescence interference

Application Process

The ruthenium complex was covalently linked to a model protein through hydroxyl-functionalized bipyridyl ligands. Fluorescence spectroscopy and lifetime measurements were conducted under physiological buffer conditions.

The labeled protein was subsequently used in Förster resonance energy transfer (FRET)-related interaction studies.

Results and Findings

Experimental evaluation demonstrated:

• The ruthenium complex retained approximately 93% of its fluorescence intensity after storage in PBS buffer (pH 7.4) for 72 h.
• The fluorescence lifetime reached approximately 610 ns, significantly longer than conventional organic fluorophores, which typically exhibit lifetimes below 10 ns.
• Protein conjugation efficiency reached approximately 84%.
• In FRET-based interaction assays, fluorescence response increased by approximately 2.6-fold following target protein binding.
• Time-resolved fluorescence measurements reduced background fluorescence by approximately 41%.
• Relative standard deviation (RSD) across three experimental batches remained below 4.2%.

The results confirmed that the product provided excellent stability, high reproducibility, and reliable performance for time-resolved fluorescence analysis and protein interaction studies.

Customer Feedback

"Researchers reported that the product showed excellent water compatibility and stable optical performance throughout extended experimental cycles. The consistent fluorescence lifetime characteristics significantly improved assay reproducibility."

Experimental Objective

The project aimed to:

• Visualize intracellular nucleic acid localization
• Investigate DNA-binding behavior in live cells
• Improve fluorescence stability during prolonged microscopy observation
• Develop a robust nucleic acid imaging platform

Application Process

The ruthenium complex was introduced into cultured cancer cells and incubated under controlled experimental conditions. Cellular uptake and nucleic acid localization were analyzed using fluorescence microscopy and spectroscopic characterization techniques.

Comparative experiments were conducted against commercially available nucleic acid dyes.

Results and Findings

The study demonstrated:

• Fluorescence intensity increased by approximately 6.3-fold after DNA binding.
• The DNA-binding constant (Kb) reached approximately 1.7 × 10⁶ M⁻¹, indicating strong nucleic acid affinity.
• After 20 consecutive laser scanning cycles, approximately 85% fluorescence intensity was retained, whereas the commercial nucleic acid dye control retained only approximately 48%.
• Nuclear fluorescence intensity was approximately 5.1 times higher than cytoplasmic fluorescence intensity.
• Cellular uptake experiments showed clear nuclear localization within 4 h of incubation.
• Cell viability remained above 90% at a working concentration of 5 μM.

The research team concluded that the ruthenium complex combined excellent DNA-binding capability, high photostability, and low background interference, making it highly suitable for live-cell nucleic acid imaging and DNA interaction studies.

Customer Feedback

"The research team noted that the product delivered highly stable fluorescence signals and excellent DNA-binding specificity, making it particularly valuable for long-term cellular imaging and nucleic acid interaction studies."